Holen Sie sich die Stockscreener-App
1.15
3.36%
-0.04
Handel nachbörslich:
1.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-30 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
21.96%
8.788
|
11.26 | 10.04 | 11.05 | 10.63 |
| Operating Income/Loss |
21.96%
-8.788
|
-11.26 | -10.04 | -11.05 | -10.63 |
| Nonoperating Income/Loss |
1,230%
-0.1516
|
0.0134 | 0.0226 | 0.1173 | 0.2048 |
| Income/Loss From Continuing Operations Before Tax |
20.52%
-8.9396
|
-11.25 | -10.28 | -10.93 | -10.43 |
| Income Tax Expense/Benefit, Deferred |
0.2642
|
- | - | 0.144 | 0.144 |
| Income Tax Expense/Benefit |
0.00%
0.2642
|
0.2642 | 0.2642 | 0.144 | 0.144 |
| Income/Loss From Continuing Operations After Tax |
20.05%
-9.2039
|
-11.51 | -10.28 | -11.08 | -10.57 |
|
Net Income/Loss
|
20.05%
-9.2039
|
-11.51 | -10.28 | -11.08 | -10.57 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | -0.3216 | 0.3216 |
| Attributable To Noncontrolling Interest |
30.42%
-0.414
|
-0.595 | - | -0.287 | - |
| Basic Average Shares |
28.27%
11.01
|
8.5812 | -0.5514 | -157.22 | 173.86 |
| Diluted Average Shares |
28.27%
11.01
|
8.5812 | -0.5514 | -157.22 | 173.86 |
| Basic Earnings Per Share |
37.01%
-0.80
|
-1.27 | -1.31 | - | - |
| Diluted Earnings Per Share |
37.01%
-0.80
|
-1.27 | -1.31 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | -0.3216 | 0.3216 |
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):